Thiotepa-based High-dose Chemotherapy with Autologous Stem Cell Rescue in Children with High-risk Medulloblastoma

被引：0
|
作者：
Sajiki, Daichi [1 ]
Maemura, Ryo [1 ]
Yamamori, Ayako [1 ]
Wakamatsu, Manabu [1 ]
Sakaguchi, Hirotoshi [1 ]
Yoshida, Nao [1 ]
Hatano, Hisashi [2 ]
Kato, Koji [1 ]
机构：
[1] Japanese Red Cross Nagoya First Hosp, Childrens Med Ctr, Dept Hematol & Oncol, Nagoya, Aichi, Japan
[2] Japanese Red Cross Nagoya First Hosp, Dept Neurosurg, Nagoya, Aichi, Japan
来源：
PEDIATRIC BLOOD & CANCER | 2017年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
O14-1-1
引用
收藏
页码：S55 / S55
页数：1
相关论文
共 50 条
  • [1] Thiotepa-based conditioning and autologous stem cell transplantation in children with high-risk medulloblastoma
    Daylidite, V.
    Mentkevich, G.
    Dolgopolov, I.
    Subbotina, N.
    Levashov, A.
    Babelyan, S.
    Boyarshinov, V.
    Zagidullina, S.
    LEUKEMIA RESEARCH, 2019, 85 : S23 - S24
  • [2] Thiotepa-Based Conditioning and Autologous Stem Cell Transplantation in Children with High-Risk Medulloblastoma
    Daylidite, V.
    Mentkevich, G.
    Dolgopolov, I.
    Subbotina, N.
    Levashov, A.
    Babelyan, S.
    PEDIATRIC BLOOD & CANCER, 2018, 65 : S432 - S432
  • [3] Thiotepa-based high-dose chemotherapy with autologous stem cell transplantation for neurolymphomatosis
    Toru Miyajima
    Reiki Ogasawara
    Shihori Tsukamoto
    Takashi Ishio
    Emi Yokoyama
    Koh Izumiyama
    Akio Mori
    Makoto Saito
    Masanobu Morioka
    Takeshi Kondo
    International Journal of Hematology, 2023, 118 : 141 - 145
  • [4] Thiotepa-based high-dose chemotherapy with autologous stem cell transplantation for neurolymphomatosis
    Miyajima, Toru
    Ogasawara, Reiki
    Tsukamoto, Shihori
    Ishio, Takashi
    Yokoyama, Emi
    Izumiyama, Koh
    Mori, Akio
    Saito, Makoto
    Morioka, Masanobu
    Kondo, Takeshi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2023, 118 (01) : 141 - 145
  • [5] Results of tandem high-dose chemotherapy and autologous stem cell transplantation using thiotepa in children with high-risk medulloblastoma
    Daylidite, V.
    Daylidite, Vidmante V.
    Subbotina, Natalia N.
    Dolgopolov, Igor S.
    Babelyan, Stepan S.
    Levashow, Andrey S.
    Mentkevich, Georgy L.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S513 - S513
  • [6] High-dose chemotherapy with autologous stem-cell rescue in children with high-risk medulloblastoma/PNET.
    Konoplya, N.
    Strongin, U.
    Aleynikova, O.
    EJC SUPPLEMENTS, 2005, 3 (02): : 357 - 357
  • [7] High-dose chemotherapy containing topotecan, thiotepa and carboplatin with autologous stem cell rescue for high-risk medulloblastorna
    Muramatsu, H
    Matsumoto, K
    Kato, K
    Inao, S
    BONE MARROW TRANSPLANTATION, 2005, 35 : S390 - S390
  • [8] High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma
    Yalcin, Bilgehan
    Kremer, Leontien C. M.
    Caron, Huib N.
    van Dalen, Elvira C.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2013, (08):
  • [9] High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma
    Yalcin, Bilgehan
    Kremer, Leontien C. M.
    Caron, Huib N.
    van Dalen, Elvira C.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2010, (05):
  • [10] High-dose chemotherapy and autologous haematopoietic stem cell rescue for children with high-risk neuroblastoma
    Yalcin, Bilgehan
    Kremer, Leontien C. M.
    van Dalen, Elvira C.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2015, (10):
12345